Lunaphore Technologies, a Swiss company founded in 2014, has developed a tumor analysis platform based on microfluidic chip technology. Their innovative solutions enable faster and more precise cancer diagnostics assays, accelerating cancer research and bringing spatial biology into mainstream laboratories.